Corrigendum: Intrathecal drug delivery: Advances and applications in the management of chronic pain patient

Front Pain Res (Lausanne). 2023 Apr 11:4:1190014. doi: 10.3389/fpain.2023.1190014. eCollection 2023.

Jose De Andres^{1

2}, Salim Hayek³, Christophe Perruchoud^{4

5}, Melinda M Lawrence³, Miguel Angel Reina^{6

7

8

9}, Carmen De Andres-Serrano¹⁰, Ruben Rubio-Haro^{11

10}, Mathew Hunt¹², Tony L Yaksh¹³

¹ Surgical Specialties Department, Valencia University Medical School, Valencia, Spain.
² Anesthesia Critical Care and Pain Management Department, Valencia, Spain.
³ Department of Anesthesiology, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.
⁴ Pain Center and Department of Anesthesia, La Tour Hospital, Geneva, Switzerland.
⁵ Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁶ Department of Anesthesiology, Montepríncipe University Hospital, Madrid, Spain.
⁷ CEU-San-Pablo University School of Medicine, Madrid, Spain.
⁸ Department of Anesthesiology, University of Florida College of Medicine, Gainesville, FL, United States.
⁹ Facultad de Ciencias de la Salud Universidad Francisco de Vitoria, Madrid, Spain.
¹⁰ Multidisciplinary Pain Clinic, Vithas Virgen del Consuelo Hospital, Valencia, Spain.
¹¹ Anesthesia and Pain Management Department, Provincial Hospital, Castellon, Spain.
¹² Department of Physiology, Karolinska Institute, Stockholm, Sweden.
¹³ Departments of Anesthesiology and Pharmacology, University of California, San Diego, San Diego, CA, United States.

Abstract

[This corrects the article DOI: 10.3389/fpain.2022.900566.].

Keywords: antisense; chronic pain; implantable drug delivery system (IDDS); intrathecal; neuromodulation.